543.95 -0.15 (-0.03%)
Before hours: 9:26AM EST
|Bid||544.00 x 1000|
|Ask||544.00 x 1100|
|Day's range||542.14 - 556.95|
|52-week range||328.13 - 664.64|
|Beta (5Y monthly)||0.30|
|PE ratio (TTM)||19.94|
|Earnings date||05 Feb 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||660.56|
Johnson and Johnson expects vaccine data next week.
Columbia University researchers and Regeneron have independently confirmed findings; data included in bioRxiv paper and submitted for peer-reviewed publication
Investors will want to scoop up shares of this diversified drugmaker and coronavirus vaccine developer before it's too late.